Acute Biphenotypic Leukemia (ABL) Withdrawn Phase 2 Trials for Fludarabine (DB01073)

Also known as: Acute biphenotypic leukaemia / Acute Biphenotypic Leukemia / Leukemia, Biphenotypic, Acute / Acute bilineal leukemia

IndicationStatusPhase
DBCOND0081399 (Acute Biphenotypic Leukemia (ABL))Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03399773Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Hematologic MalignanciesTreatment